Genocea Biosciences
GNCA
$0.0001000
Share price
-85.71%
Change (1 day)
N/A
Change (1 year)
Categories
P/S ratio for Genocea Biosciences (GNCA)
P/S ratio as of April 2024 (TTM): 0.0031
According to Genocea Biosciences 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.00307588. At the end of 2022 the company had a P/S ratio of 38.4.
P/S ratio history for Genocea Biosciences from 2014 to 2022
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2022 | 38.4 | -5.39% |
| 2021 | 40.6 | -55.84% |
| 2020 | 91.9 | |
| 2019 | N/A | |
| 2018 | N/A | |
| 2017 | N/A | -100% |
| 2016 | 498 | 124.71% |
| 2015 | 221 | -45.42% |
| 2014 | 406 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 2.46 | 79,835.82% | 🇺🇸 USA |
 Merck MRK | 5.53 | 179,633.60% | 🇺🇸 USA |
 Novavax NVAX | 0.8254 | 26,735.77% | 🇺🇸 USA |
 Agenus
AGEN | 1.57 | 50,827.21% | 🇺🇸 USA |
 iBio IBIO | 303 | 9,854,738.29% | 🇺🇸 USA |